Schedule II Presentations - Previously Recorded
The Educational Streaming Media Program at Cincinnati Children's Hospital Medical Center provides Advanced Pharmacy Series for Prescribers via streaming media. These presentations meet the six hour continuing education requirement for Schedule II Controlled Substance.
AMA PRA Category 1 Credit™ can be obtained after viewing the presentation within one year of the originally aired date. If you have any questions, please contact the Continuing Medical Education office cme@cchmc.org or 513-636-6732.
Please do not proceed with viewing until you have read the important CME Credit Overview.
If you would like to view previously recorded Advanced Pharmacy Series for Prescribers lectures, please click here.
2012 Schedule II Webcasts
- SCHEDULE II CONTROLLED SUBSTANCE: Clinical Practice Guidelines for Treatment of ADHD with Stimulant Medications
Susan Franer, CNS
Division of Psychiatry
View Lecture Here
Originally aired on November 8, 2012
To print the presentation, view the PowerPoint pdf here.
To complete the post-test and evaluation, a link is embedded in the video's "links" section. It is marked with a double paperclip.
- Planning committee members/faculty were determined to have no conflicts of interest pertaining to this activity.
Commercial support: None
- SCHEDULE II CONTROLLED SUBSTANCE: Fiscal and Ethical Implications of Prescribing Schedule II Controlled Substances/Overview of Schedule II Substances
Ashley Nebbia, PharmD
Clinical Pharmacy Specialist, Acute Care, Division of Pharmacy
View Lecture Here
Originally aired on November 8, 2012
To print the presentation, view the PowerPoint pdf here.
To complete the post-test and evaluation, a link is embedded in the video's "links" section. It is marked with a double paperclip.
- Planning committee members/faculty were determined to have no conflicts of interest pertaining to this activity.
Commercial support: None
- SCHEDULE II CONTROLLED SUBSTANCE: Chronic Pain/Pain Management Guidelines
Kenneth Goldschneider, MD, FAAP
Director, Division of Pain Management
Associate Professor, Division of Pediatric Anesthesia
View Lecture Here
Originally aired on November 7, 2012
To print the presentation, view the PowerPoint pdf here.
To complete the post-test and evaluation, a link is embedded in the video's "links" section. It is marked with a double paperclip.
- Planning committee members/faculty were determined to have no conflicts of interest pertaining to this activity.
Commercial support: None
- SCHEDULE II CONTROLLED SUBSTANCE: Ohio Automated Rx Reporting System
Betty Jones, RPh
Compliance Specialist, Ohio State Board of Pharmacy
View Lecture Here
Originally aired on November 7, 2012
To print the presentation, view the PowerPoint pdf here.
To complete the post-test and evaluation, a link is embedded in the video's "links" section. It is marked with a double paperclip.
- Planning committee members/faculty were determined to have no conflicts of interest pertaining to this activity.
Commercial support: None
- SCHEDULE II CONTROLLED SUBSTANCE: Laws and Rules: Schedule II Controlled Substances
Mandi Cafasso, CNP
View Lecture Here
Originally aired on November 6, 2012
To print the presentation, view the PowerPoint pdf here.
To complete the post-test and evaluation, a link is embedded in the video's "links" section. It is marked with a double paperclip.
- Planning committee members/faculty were determined to have no conflicts of interest pertaining to this activity.
Commercial support: None
- SCHEDULE II CONTROLLED SUBSTANCE: Abuse and Diversion of Schedule II Controlled Substances
Dennis Luken
Pharmaceutical Diversion Resources, Inc.
View Lecture Here
Originally aired on November 6, 2012
To print the presentation, view the PowerPoint pdf here.
To complete the post-test and evaluation, a link is embedded in the video's "links" section. It is marked with a double paperclip.
- Planning committee members/faculty were determined to have no conflicts of interest pertaining to this activity.
Commercial support: None
|
